ELITE Vial Kit with sterile Gx® RTF vials
Our new ELITE Vial Kit consists of sterile Gx® RTF vials in EZ Fill tray (in stock) and nest & tub (special order) with matching closures and is tailored to support the development of new drugs, vaccines and biologics in early phases. The Vision BioPharma ELITE Kit is suitable for small batch manufacturing from first-line trials to validation and clinical batches. It can be ordered in six different configurations of Gx® RTF glass vials. Kits including Gx® ELITE and Gx® RTF COP vials will follow soon.
Benefits and properties of our ELITE Vial Kit
- Sterile Gx® RTF glass vials in EZ Fill tray (in stock) and nest & tub (special order)
- Superior Gx® Elite vials also available in ready-to-fill
- Selected range of stoppers and seals
- All-in-one solutions ready-to-use for small and clinical batches
- Same Gx® RTF vial platform for large scale manufacturing
- Compatible with standard and robotized filling lines
- Reduced time-to-market
Standard configurations and customized kits
The ELITE Vial Kit provides a complete set of primary packaging containers and containment solutions, especially selected for high value drugs and/or most complex and demanding drugs. It complies with GMP requirements to produce clinical batches. It is currently offered in 6 different configurations with EZ Fill tray (in stock) and nest & tub (special order) for filling volumes 2R, 6R and 10R.
Proven product features are ensured with each kit, such as the integrity of the container system. With our experts’ help, your individual kit can be created from the selected range of closure components.
Additional integrated services
Vision BioPharma accompanies and supports you from the early phase through to life cycle management. With a network of selected partners, we provide expertise regarding regulatory implementation, development path, and market approach or strategies for the packaging and administration of drugs.
Our analytical laboratory services include E&L studies (components and systems), material characterization according to ISO 10993-18:2020, biocompatibility studies according to the 10993 series, toxicological risk assessment and consulting services and BEP/BER writing services.